Published in Patient Prefer Adherence on February 04, 2010
Diet or exercise interventions vs combined behavioral weight management programs: a systematic review and meta-analysis of direct comparisons. J Acad Nutr Diet (2014) 1.05
Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: systematic review and meta-analysis. Obes Rev (2014) 0.94
Duloxetine use in chronic painful conditions--individual patient data responder analysis. Eur J Pain (2013) 0.88
Independent validation of the Pain Management Plan in a multi-disciplinary pain team setting. Br J Pain (2016) 0.75
Mediation of Short and Longer Term Effects of an Intervention Program to Enhance Resilience in Immigrants from Mainland China to Hong Kong. Front Psychol (2015) 0.75
Implementing an acceptance and commitment therapy group protocol with veterans using VA's stepped care model of pain management. J Behav Med (2015) 0.75
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Pharm Stat (2008) 2.06
Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry (2003) 2.03
Factors associated with early study discontinuation in AACTG studies, DACS 200. Contemp Clin Trials (2007) 1.39
Comparison of alternative strategies for analysis of longitudinal trials with dropouts. J Biopharm Stat (2002) 1.37
Efficacy and safety of duloxetine in patients with chronic low back pain. Spine (Phila Pa 1976) (2010) 1.24
Baseline observation carry forward: reasoning, properties, and practical issues. J Biopharm Stat (2009) 1.13
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain (2009) 2.69
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract (2011) 1.50
Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. J Am Acad Child Adolesc Psychiatry (2008) 1.35
Highly efficient syntheses of azetidines, pyrrolidines, and indolines via palladium catalyzed intramolecular amination of C(sp3)-H and C(sp2)-H bonds at γ and δ positions. J Am Chem Soc (2011) 1.26
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry (2004) 1.23
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett (2010) 1.19
Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment. Psychother Psychosom (2002) 1.17
Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain (2010) 1.14
Treatment approaches to major depressive disorder relapse. Part 1: dose increase. Psychother Psychosom (2002) 1.13
CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry (2007) 1.05
MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun (2011) 1.05
Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J (2009) 1.04
A comparison of North American versus non-North American ADHD study populations. Eur Child Adolesc Psychiatry (2006) 1.03
Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials. Diabetes Care (2007) 1.03
Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population. Clin Cancer Res (2009) 1.00
Associations between Bacillus subtilis sigmaB regulators in cell extracts. Microbiology (2004) 0.98
miRNA: The nemesis of gastric cancer (Review). Oncol Lett (2013) 0.95
VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression. Cytokine (2011) 0.95
MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3. Int J Biol Sci (2011) 0.94
Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes. Muscle Nerve (2007) 0.94
Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry (2009) 0.94
Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells. J Biol Chem (2012) 0.93
Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Dev Med Child Neurol (2007) 0.92
A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year. Biol Psychiatry (2006) 0.91
Effects of different cold-air exposure intensities on the risk of cardiovascular disease in healthy and hypertensive rats. Int J Biometeorol (2013) 0.91
Effects of cold air on cardiovascular disease risk factors in rat. Int J Environ Res Public Health (2012) 0.91
Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo. J Child Psychol Psychiatry (2009) 0.90
General and efficient strategy for erythrinan and homoerythrinan alkaloids: syntheses of (+/-)-3-demethoxyerythratidinone and (+/-)-erysotramidine. Org Lett (2006) 0.90
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. Eur Child Adolesc Psychiatry (2004) 0.90
Predictors of premature discontinuation of treatment in multiple disease states. Patient Prefer Adherence (2009) 0.90
Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. Mayo Clin Proc (2011) 0.89
Upregulation of Ying Yang 1 (YY1) suppresses esophageal squamous cell carcinoma development through heme oxygenase-1. Cancer Sci (2013) 0.88
Artificial cold air increases the cardiovascular risks in spontaneously hypertensive rats. Int J Environ Res Public Health (2012) 0.88
Burden of illness and treatment patterns for patients with fibromyalgia. Pain Med (2012) 0.87
Overexpression of DNA polymerase iota (Polι) in esophageal squamous cell carcinoma. Cancer Sci (2012) 0.86
Baseline values from the electrocardiograms of children and adolescents with ADHD. Child Adolesc Psychiatry Ment Health (2007) 0.85
Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2009) 0.85
Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas. Jpn J Clin Oncol (2012) 0.85
Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder. Drug Saf (2008) 0.85
Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study. Clin J Pain (2012) 0.85
Hsa-miR-196a2 functional SNP is associated with severe toxicity after platinum-based chemotherapy of advanced nonsmall cell lung cancer patients in a Chinese population. J Clin Lab Anal (2012) 0.85
Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China. Chin Med J (Engl) (2010) 0.84
Pax4 paired domain mediates direct protein transduction into mammalian cells. Endocrinology (2007) 0.84
Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo. Radiat Oncol (2014) 0.83
Designing clinical trials for the treatment of delirium. J Psychosom Res (2008) 0.83
Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence. Am J Addict (2009) 0.83
Bryostatin-5 blocks stromal cell-derived factor-1 induced chemotaxis via desensitization and down-regulation of cell surface CXCR4 receptors. Cancer Res (2008) 0.82
Upregulation of PAX2 promotes the metastasis of esophageal cancer through interleukin-5. Cell Physiol Biochem (2015) 0.81
Efficacy of Duloxetine in Patients with Chronic Pain Conditions. Curr Drug ther (2011) 0.81
miR-146a gene polymorphism rs2910164 and the risk of digestive tumors: A meta-analysis of 21 case-control studies. Oncol Rep (2013) 0.81
OTUD5 regulates p53 stability by deubiquitinating p53. PLoS One (2013) 0.80
Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. Biol Psychiatry (2006) 0.80
Integrating microRNA and mRNA expression profiles in response to radiation-induced injury in rat lung. Radiat Oncol (2014) 0.80
Dihydroartemisinin induces radiosensitivity in cervical cancer cells by modulating cell cycle progression. Saudi Med J (2013) 0.79
Genetic variants in GTF2H1 and risk of lung cancer: a case-control analysis in a Chinese population. Lung Cancer (2008) 0.79
Efficacy of duloxetine versus alternative oral therapies: an indirect comparison of randomised clinical trials in chronic low back pain. Eur Spine J (2013) 0.79
Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine. J Clin Psychiatry (2004) 0.78
Molecular handcuffing of the relaxosome at the origin of conjugative transfer of the plasmid R1162. Nucleic Acids Res (2003) 0.78
Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study. Pain Med (2010) 0.78
A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative. Pain (2012) 0.78
A stroke-like presentation of glioblastoma multiforme. J Stroke Cerebrovasc Dis (2003) 0.78
LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo. Tumour Biol (2014) 0.77
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2006) 0.77
Synthesis of phenanthridines via palladium-catalyzed picolinamide-directed sequential C-H functionalization. Beilstein J Org Chem (2013) 0.76
Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine. Psychiatry Res (2009) 0.76
Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial. Curr Med Res Opin (2011) 0.76
Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials. Pain Res Treat (2012) 0.75
Proteasome inhibitor MG132 enhances the antigrowth and antimetastasis effects of radiation in human nonsmall cell lung cancer cells. Tumour Biol (2014) 0.75
SeeDNA: a visualization tool for K-string content of long DNA sequences and their randomized counterparts. Genomics Proteomics Bioinformatics (2004) 0.75
Transcriptome analysis of canine cardiac fat pads: involvement of two novel long non-coding RNAs in atrial fibrillation neural remodeling. J Cell Biochem (2015) 0.75
Correction to "Highly Efficient Syntheses of Azetidines, Pyrrolidines, and Indolines via Palladium-Catalyzed Intramolecular Amination of C(sp3)-H and C(sp2)-H Bonds at γ and δ Positions". J Am Chem Soc (2016) 0.75
A novel method for identifying shahtoosh. J Forensic Sci (2014) 0.75
Formation of crystalline nanoparticles by iron binding to pentapeptide (Asp-His-Thr-Lys-Glu) from egg white hydrolysates. Food Funct (2017) 0.75
All-inorganic perovskite-based distributed feedback resonator. Opt Express (2017) 0.75
Nanopatterned luminescent concentrators for visible light communications. Opt Express (2017) 0.75
[Identification of bryostatins in Bugula neritina extracts by high performance liquid chromatography and Q-Tof mass spectrometry]. Se Pu (2004) 0.75
[Screenings of 23 plant species in Beijing for volatile organic compound emissions]. Huan Jing Ke Xue (2003) 0.75
Organic photovoltaics and energy: general discussion. Faraday Discuss (2014) 0.75
Photonics: general discussion. Faraday Discuss (2014) 0.75
Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis. Clin Ther (2012) 0.75
Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells. Tumour Biol (2014) 0.75
Analysis of the interactions between the peptides from secreted human CKLF1 and heparin using capillary zone electrophoresis. J Pept Sci (2008) 0.75
[MicroRNA-146a polymorphism and susceptibility to gastrointestinal cancer: a meta-analysis]. Zhonghua Wei Chang Wai Ke Za Zhi (2015) 0.75